Member Login
  1. Stocks
    2. /
  2. Bausch Health Companies Inc. (NYSE: BHC)
    3. /

NYSE:BHC (Bausch Health Companies Inc.)

About BHC

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Bausch Health Companies Inc. (NYSE: BHC) Latest News

    The Motley Fool
    Investing

    Should Investors Avoid Concordia Healthcare Corp.?

    | Jacob Donnelly

    Concordia Healthcare Corp. (TSX:CXR)(NASDAQ:CXRX) is being held back due to political pressure on a competitor, but does the recent acquisition…

    Read more »

    The Motley Fool
    Investing

    2 Ways That Valeant Pharmaceuticals Intl Inc. Shares Could Get Crushed

    | Benjamin Sinclair

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has some big problems on its hands.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. May Not Be an Enron, But Trouble Lies Ahead

    | Benjamin Sinclair

    Now is not the time to own Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »

    The Motley Fool
    Investing

    Concordia Healthcare Corp.: Is This Stock as Bad as Valeant Pharmaceuticals Intl Inc.?

    | Nelson Smith

    Concordia Healthcare Corp. (TSX:CRX)(NASDAQ:CXRX) has fallen in sympathy with Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX). Is now a buying opportunity?

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Intl Inc. the Next Enron?

    | Nelson Smith

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is the target of an aggressive short-selling campaign. Is it the next Enron, or is…

    Read more »

    The Motley Fool
    Investing

    Why Are Valeant Pharmaceuticals Intl Inc. Shares in Absolute Free Fall?

    | Benjamin Sinclair

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may be misleading investors. The consequences could be disastrous.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Tries to Downplay the Drug-Pricing Scandal

    | Doug Watt

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has been caught up in a drug-pricing scandal. What are the long-term implications for the…

    Read more »

    The Motley Fool
    Dividend Stocks

    Long-Term Investors: Here Are 3 Stocks for Future Growth

    | Demetris Afxentiou

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), Canadian National Railway Company (TSX:CNR)(NYSE:CNI), and Agrium Inc. (TSX:AGU)(NYSE:AGU) are three of the best-performing stocks…

    Read more »

    The Motley Fool
    Investing

    Why Did Valeant Pharmaceuticals Intl Inc. Plunge Another 9%?

    | Benjamin Sinclair

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has a target on its back.

    Read more »

    The Motley Fool
    Investing

    Should You Buy Valeant Pharmaceuticals Intl Inc. Before its Earnings Report?

    | Kay Ng

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is down 30% from recent highs. Is it a double-digit opportunity, or should you watch…

    Read more »

    The Motley Fool
    Investing

    2 Triple-Digit Stocks Worth Every Penny: Part 3

    | Joseph Solitro

    Canadian Pacific Railway Limited (TSX:CP)(NYSE:CP) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may have high stock prices, but they are both…

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Intl Inc. a Buy After Recent Volatility?

    | Jacob Donnelly

    Due to the recent political fire, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) might be worth avoiding. But for riskier investors, it…

    Read more »